Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kenneth R. Pitzer currently holds 380,123 shares of Theravance Biopharma, Inc. (TBPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kenneth R. Pitzer has been a net neutral trader of TBPH stock. They have purchased $0 and sold $0 worth of shares.
Kenneth R. Pitzer's most recent insider trade was on Feb 18, 2022, when they sold 27,299 shares at $9.61 per share.
Kenneth R. Pitzer serves as Executive at Theravance Biopharma, Inc. (TBPH). They have executed 33 insider transactions totaling $0 over their tenure at the company.
Kenneth R. Pitzer holds the position of Executive at Theravance Biopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Kenneth R. Pitzer has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Kenneth R. Pitzer was on Feb 20, 2020, when they sold $754.6K worth of TBPH shares. This transaction involved 29,136 shares at $25.90 per share.
Kenneth R. Pitzer currently owns 380,123 shares of Theravance Biopharma, Inc. (TBPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kenneth R. Pitzer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kenneth R. Pitzer has 33 Form 4 filings on record as an insider at Theravance Biopharma, Inc..
Set alerts for Kenneth R. Pitzer and 40,000+ other insiders.